The manufacturer of Testim® has advised that it intends to cease production and supply of this product in 2018.
The product is currently out of stock but supplies are expected to be delivered in early 2018, currently estimated as February. However, once this delivery of stock has been made it seems the product will be discontinued with no further supplies being made. The manufacturer stresses that the decisions to discontinue this product is not due to issues regarding safety, quality or efficacy of the product.
Testim® contains 50 mg of testosterone in a 5g unit dose container. Testogel® would appear to be a reasonable replacement; it contains the same strength of testosterone in the same unit dose presentation.
Action: Clinicians should be aware of this product being discontinued. It would be prudent to run clinical system searches to identify any patients who are currently prescribed this product to allow suitable alternatives to be arranged.
|« NICE Guidance - December 2017||Drug Safety Update - January 2018 »|